The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks

Takahiro Okumura; Toyoaki Murohara

doi:10.1038/s41440-024-01772-x

The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks

Takahiro Okumura
, Toyoaki Murohara

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

本文言語	英語
ページ（範囲）	2598-2600
ページ数	3
ジャーナル	Hypertension Research
巻	47
号	9
DOI	https://doi.org/10.1038/s41440-024-01772-x
出版ステータス	出版済み - 09-2024
外部発表	はい

All Science Journal Classification (ASJC) codes

内科学
生理学
循環器および心血管医学

文献へのアクセス

10.1038/s41440-024-01772-x

他のファイルとリンク

引用スタイル

@article{2f69ab620a004a39a4a899268c00adf1,

title = "The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks",

keywords = "Angiotensin receptor blockers, Angiotensin-converting enzyme inhibitors, COVID-19",

author = "Takahiro Okumura and Toyoaki Murohara",

year = "2024",

month = sep,

doi = "10.1038/s41440-024-01772-x",

language = "English",

volume = "47",

pages = "2598--2600",

journal = "Hypertension Research",

issn = "0916-9636",

publisher = "Springer Nature",

number = "9",

}

TY - JOUR

T1 - The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19

T2 - balancing cardiovascular benefits and viral risks

AU - Okumura, Takahiro

AU - Murohara, Toyoaki

PY - 2024/9

Y1 - 2024/9

KW - Angiotensin receptor blockers

KW - Angiotensin-converting enzyme inhibitors

KW - COVID-19

UR - https://www.scopus.com/pages/publications/85197287500

UR - https://www.scopus.com/pages/publications/85197287500#tab=citedBy

U2 - 10.1038/s41440-024-01772-x

DO - 10.1038/s41440-024-01772-x

M3 - Comment/debate

C2 - 38951682

AN - SCOPUS:85197287500

SN - 0916-9636

VL - 47

SP - 2598

EP - 2600

JO - Hypertension Research

JF - Hypertension Research

IS - 9

ER -